Follow
Mohanad H. Nada
Mohanad H. Nada
Assistant Professor of Pathology
Verified email at uiowa.edu
Title
Cited by
Cited by
Year
Enhancing adoptive cancer immunotherapy with Vγ2Vδ2 T cells through pulse zoledronate stimulation
MH Nada, H Wang, G Workalemahu, Y Tanaka, CT Morita
Journal for immunotherapy of cancer 5, 1-23, 2017
602017
Expansion of human γδ T cells for adoptive immunotherapy using a bisphosphonate prodrug
Y Tanaka, K Murata‐Hirai, M Iwasaki, K Matsumoto, K Hayashi, ...
Cancer science 109 (3), 587-599, 2018
482018
Metabolic engineering of Salmonella vaccine bacteria to boost human Vγ2Vδ2 T cell immunity
G Workalemahu, H Wang, KJ Puan, MH Nada, T Kuzuyama, BD Jones, ...
The Journal of Immunology 193 (2), 708-721, 2014
232014
PD-1 checkpoint blockade enhances adoptive immunotherapy by human Vγ2Vδ2 T cells against human prostate cancer
MH Nada, H Wang, AJ Hussein, Y Tanaka, CT Morita
Oncoimmunology 10 (1), 1989789, 2021
192021
Critical roles for coiled-coil dimers of butyrophilin 3A1 in the sensing of prenyl pyrophosphates by human Vγ2Vδ2 T cells
H Wang, MH Nada, Y Tanaka, S Sakuraba, CT Morita
The Journal of Immunology 203 (3), 607-626, 2019
172019
83P The efficacy of combining adoptive immunotherapy by human Vγ2Vδ2 T cells and PD-1 checkpoint blockade against human prostate cancer
MH Nada, A Hussein, H Wang, C Morita
Annals of Oncology 33, S1409, 2022
2022
IL-18 improves the anti-cancer immunity of human gamma delta T cells against prostate cancer
MH Nada, AJ Hussein, H Wang, CT Morita
Annals of Oncology 31 (March, 2020), S3-S4, 2020
2020
Attenuated Listeria vaccine for cancer immunotherapy expands Vγ2Vδ2 T cells in rhesus monkeys that retain their central memory phenotype and HMBPP responsiveness
CT Morita, MHN Al-Janabi, G Workalemahu, H Wang
The Journal of Immunology 202 (1_Supplement), 138.16-138.16, 2019
2019
PD-1 checkpoint blockade enhances adoptive immunotherapy by human Vγ2Vδ2 T cells against human prostate cancer
MH Nada, AJ Hussein, H Wang, C Morita
European Journal of Cancer 110, S23, 2019
2019
PD-1 checkpoint blockade therapy enhances adoptive immunotherapy by human Vγ2Vδ2 T cells against prostate tumors in a preclinical model
MH Nada, H Wang, C Morita
Cancer Research 78 (13_Supplement), 3628-3628, 2018
2018
PD-1 blockade markedly enhances immunity to prostate tumors by adoptively transferred human Vγ2Vδ2 T cells in an NSG mouse model
CT Morita, H Wang, MH Nada
The Journal of Immunology 200 (1_Supplement), 122.13-122.13, 2018
2018
Optimizing adoptive cancer immunotherapy with Vγ2Vδ2 T cells through zoledronate pulse stimulation
MH Nada, H Wang, G Workalemahu, Y Tanaka, CT Morita
The Journal of Immunology 196 (1 Supplement), 143.16-143.16, 2016
2016
Adoptive cancer immunotherapy with human Vγ2vδ2 T cells
MH Nada
The University of Iowa, 2016
2016
Optimizing adoptive cancer immunotherapy with γδ T cells through “pulse” zoledronate stimulation and IL-15 (TUM2P. 886)
M Nada, H Wang, G Workalemahu, C Morita
The Journal of Immunology 192 (1_Supplement), 71.10-71.10, 2014
2014
The system can't perform the operation now. Try again later.
Articles 1–14